Amazon’s Bio Discovery tool pushes AI deeper into drug design with lab testing already under way

AWS has launched Amazon Bio Discovery, an AI application aimed at speeding early-stage drug research. Amazon says Memorial Sloan Kettering used the system to compress an antibody design process from a year into weeks, an early signal that AI drug discovery is moving from pitch decks to workflow.

By |2026-04-23T03:48:47+00:00April 23, 2026|News|Comments Off on Amazon’s Bio Discovery tool pushes AI deeper into drug design with lab testing already under way

Google opens Veo 3.1 Lite to developers as AI video generation gets cheaper

Google has launched Veo 3.1 Lite, its most cost-effective video generation model, into the Gemini API and Google AI Studio, while also saying it will lower pricing for Veo 3.1 Fast on April 7. The move is aimed at developers building higher-volume video applications and marks a clear bid to widen adoption by reducing cost pressure in one of AI’s most compute-intensive formats.

By |2026-04-13T02:24:50+00:00April 13, 2026|News|Comments Off on Google opens Veo 3.1 Lite to developers as AI video generation gets cheaper
Go to Top